COPD pharmacology

Customer is always right: optimising inhaler design to fit patient preferences in obstructive lung disease
Andrew Gangemi, Victor Kim, Gerard Criner

Thorax Jul 2020, thoraxjnl-2020-215238; DOI: 10.1136/thoraxjnl-2020-215238
Oral nitrate supplementation to enhance pulmonary rehabilitation in COPD: ON-EPIC a multicentre, double-blind, placebo-controlled, randomised parallel group study
Matthew J Pavitt, Rebecca Jayne Tanner, Adam Lewis, Sara Buttery, Bhavin Mehta, Helen Jefford, Katrina J Curtis, Winston A S Banya, Syed Husain, Karnan Satkunam, Dinesh Shrikrishna, William Man, Michael I Polkey, Nicholas S Hopkinson

Thorax Jul 2020, 75 (7) 547-555; DOI: 10.1136/thoraxjnl-2019-214278
Association between COPD exacerbations and lung function decline during maintenance therapy
Marjan Kerkhof, Jaco Voorham, Paul Dorinsky, Claudia Cabrera, Patrick Darken, Janwillem WH Kocks, Mohsen Sadatsafavi, Don D Sin, Victoria Carter, David B Price

Thorax Jun 2020, thoraxjnl-2019-214457; DOI: 10.1136/thoraxjnl-2019-214457
British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease
David Smith, Ingrid Du Rand, Charlotte Louise Addy, Timothy Collyns, Simon Paul Hart, Philip J Mitchelmore, Najib M Rahman, Ravijyot Saggu

Thorax May 2020, 75 (5) 370-404; DOI: 10.1136/thoraxjnl-2019-213929
Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility)
Irene J Higginson, Andrew Wilcock, Miriam J Johnson, Sabrina Bajwah, Natasha Lovell, Deokhee Yi, Simon P Hart, Vincent Crosby, Heather Poad, David Currow, Emma Best, Sarah Brown

Thorax Feb 2020, 75 (2) 176-179; DOI: 10.1136/thoraxjnl-2019-213879
Carbon footprint impact of the choice of inhalers for asthma and COPD
Christer Janson, Richard Henderson, Magnus Löfdahl, Martin Hedberg, Raj Sharma, Alexander J K Wilkinson

Thorax Jan 2020, 75 (1) 82-84; DOI: 10.1136/thoraxjnl-2019-213744
Nanotechnology based therapeutics for lung disease
Mohammad Doroudian, Ronan MacLoughlin, Fergus Poynton, Adriele Prina-Mello, Seamas C Donnelly

Thorax Oct 2019, 74 (10) 965-976; DOI: 10.1136/thoraxjnl-2019-213037
One evidence base; three stories: do opioids relieve chronic breathlessness?
Magnus Ekström, Sabrina Bajwah, J Martin Bland, David C Currow, Jamilla Hussain, Miriam J Johnson

Thorax Jan 2018, 73 (1) 88-90; DOI: 10.1136/thoraxjnl-2016-209868
Hydropersulfides, the new kids in the COPD inflammatory town
Luis Puente-Maestu, Walther Ivan Girón-Matute

Thorax Dec 2017, 72 (12) 1069-1070; DOI: 10.1136/thoraxjnl-2017-210703
Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease
Daniel Kotz, Wolfgang Viechtbauer, Colin R Simpson, Onno C P van Schayck, Robert West, Aziz Sheikh

Thorax Oct 2017, 72 (10) 905-911; DOI: 10.1136/thoraxjnl-2017-210067

Main menu

COPD pharmacology

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

COPD pharmacology

Pages